Publication & Citation Trends
Publications
0 total
Dose and BTK occupancy relationship in the prospective Phase 2 TAILOR study: Exploratory end point analysis of the ibrutinib monotherapy cohorts in patients with previously untreated chronic lymphocytic leukemia
Cited by 2
Semantic Scholar
Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry. OA
Cited by 11
Semantic Scholar
First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age‐matched general population: A pooled post hoc analysis OA
Cited by 15
Semantic Scholar
Treatment with First-Line Ibrutinib Improves Overall Survival in Patients with Chronic Lymphocytic Leukemia (CLL) and High-Risk Genomic Features to Rates Approximating an Age-Matched US Population: Pooled Analysis of Phase 3 Trials with 10 Years of Follow-up
Cited by 1
Semantic Scholar
Preliminary Results from a Phase 1b Study of Non-Covalent Pan-Mutant BTK Inhibitor Docirbrutinib (AS-1763) in Patients with Previously Treated B-Cell Malignancies
Cited by 0
Semantic Scholar
MRD-directed therapy in CLL: ready for prime time?
Cited by 7
Semantic Scholar
Trial in Progress: A Phase 1b Study of AS-1763, an Oral, Potent and Selective Noncovalent BTK Inhibitor, in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma OA
Cited by 0
Semantic Scholar
Covalent Menin Inhibitor Bmf-219 in Patients with Relapsed or Refractory (R/R) Acute Leukemia (AL): Preliminary Phase 1 Data from the Covalent-101 Study OA
Cited by 26
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(332)
Lymphoma Diagnosis and Treatment
(180)
Immunodeficiency and Autoimmune Disorders
(80)
Chronic Myeloid Leukemia Treatments
(61)
Acute Lymphoblastic Leukemia research
(41)
Affiliations
Northwell Health
The Royal Melbourne Hospital
Westchester Medical Center
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Feinstein Institute for Medical Research